Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1997-03-03
2000-12-05
Myers, Carla J.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 912, 536 235, 536 2431, 536 2433, C12Q 168, C07H 2104
Patent
active
061565032
ABSTRACT:
The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of .beta.-agonists. The invention also provides kits useful for this purpose.
REFERENCES:
Reihsaus et al. American J. Resp. Cell Molec. Biol. 83:334-339, 1993.
Green et al. Biochemistry. 33: 9414-9419, 1994.
Martinez et al. Journal of Clinical Investigation. 100: 3184-3188, 1997.
Hancox, et al., "Polymorphism of the .beta..sub.2 -Adrenoceptor and the Response to Long-Term B.sub.2 -Agonist Therapy in Asthma," Eur. Respir. J., vol. 11, pp. 589-593, 1998, (month unavailable).
Sears et al., "Regular inhaled beta-agonist treatment in bronchial asthma", The Lancet, vol. 336, pp. 1391-1396, Dec. 8, 1990.
Drazen et al., "Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild Asthma" NE J. Med. 335(12):841-7, Sep. 1, 1996.
Green et al., "Influence of beta-2 adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells" Amer. J. Respir. Cell Molec. Bio.13(1):25-33, Jul. 1995.
Green et al., "Implications of genetic variability of human beta-2 adrenergic structure" Pulmon. Pharm. 8(1):1-10, Feb. 1995.
Kamada et al., "Issues in the Use of Inhaled Glucocorticoids" Americ. J Respir. Crit. Care Med. 153(6 pt 1):1739-48, Jun. 1996.
Boushey Homer
Chinchilli Vern
Drazen Jeffrey M.
Fish James E.
Ford Jean G.
Brigham and Women's Hospital
Myers Carla J.
National Jewish Medical and Research Center
The Penn State Research Foundation
The Regents of the University of California
LandOfFree
Diagnosing asthma patients predisposed to adverse .beta.-agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosing asthma patients predisposed to adverse .beta.-agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosing asthma patients predisposed to adverse .beta.-agonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-960206